Japan Branded Generics Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Branded Generics market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Branded Generics market. Detailed analysis of key players, along with key growth strategies adopted by Branded Generics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Aspen Pharmacare Holding

    • Novartis AG

    • Eva Pharmaceutical Industries

    • Sun Pharmaceutical Industries

    • Mylan NV

    • Pfizer

    • Valeant Pharmaceuticals International

    • Abbott Laboratories


    By Type:

    • Alkylating Agents

    • Antimetabolites

    • Hormones

    • Anti-Hypertensive

    • Lipid Lowering Drugs

    • Anti-Depressants

    • Anti-Psychotics

    • Anti-Epileptics

    • Other


    By End-User:

    • Oral

    • Parenteral

    • Topical

    • Other


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Branded Generics Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Branded Generics Market Size and Growth Rate of Alkylating Agents from 2014 to 2026

      • 1.3.2 Japan Branded Generics Market Size and Growth Rate of Antimetabolites from 2014 to 2026

      • 1.3.3 Japan Branded Generics Market Size and Growth Rate of Hormones from 2014 to 2026

      • 1.3.4 Japan Branded Generics Market Size and Growth Rate of Anti-Hypertensive from 2014 to 2026

      • 1.3.5 Japan Branded Generics Market Size and Growth Rate of Lipid Lowering Drugs from 2014 to 2026

      • 1.3.6 Japan Branded Generics Market Size and Growth Rate of Anti-Depressants from 2014 to 2026

      • 1.3.7 Japan Branded Generics Market Size and Growth Rate of Anti-Psychotics from 2014 to 2026

      • 1.3.8 Japan Branded Generics Market Size and Growth Rate of Anti-Epileptics from 2014 to 2026

      • 1.3.9 Japan Branded Generics Market Size and Growth Rate of Other from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Branded Generics Market Size and Growth Rate of Oral from 2014 to 2026

      • 1.4.2 Japan Branded Generics Market Size and Growth Rate of Parenteral from 2014 to 2026

      • 1.4.3 Japan Branded Generics Market Size and Growth Rate of Topical from 2014 to 2026

      • 1.4.4 Japan Branded Generics Market Size and Growth Rate of Other from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Branded Generics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Branded Generics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Branded Generics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Branded Generics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Branded Generics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Branded Generics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Branded Generics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Branded Generics Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Branded Generics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Branded Generics by Major Types

      • 3.4.1 Market Size and Growth Rate of Alkylating Agents

      • 3.4.2 Market Size and Growth Rate of Antimetabolites

      • 3.4.3 Market Size and Growth Rate of Hormones

      • 3.4.4 Market Size and Growth Rate of Anti-Hypertensive

      • 3.4.5 Market Size and Growth Rate of Lipid Lowering Drugs

      • 3.4.6 Market Size and Growth Rate of Anti-Depressants

      • 3.4.7 Market Size and Growth Rate of Anti-Psychotics

      • 3.4.8 Market Size and Growth Rate of Anti-Epileptics

      • 3.4.9 Market Size and Growth Rate of Other


    4 Segmentation of Branded Generics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Branded Generics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Branded Generics in Oral

      • 4.4.2 Market Size and Growth Rate of Branded Generics in Parenteral

      • 4.4.3 Market Size and Growth Rate of Branded Generics in Topical

      • 4.4.4 Market Size and Growth Rate of Branded Generics in Other


    5 Market Analysis by Regions

    • 5.1 Japan Branded Generics Production Analysis by Regions

    • 5.2 Japan Branded Generics Consumption Analysis by Regions


    6 Hokkaido Branded Generics Landscape Analysis

    • 6.1 Hokkaido Branded Generics Landscape Analysis by Major Types

    • 6.2 Hokkaido Branded Generics Landscape Analysis by Major End-Users


    7 Tohoku Branded Generics Landscape Analysis

    • 7.1 Tohoku Branded Generics Landscape Analysis by Major Types

    • 7.2 Tohoku Branded Generics Landscape Analysis by Major End-Users


    8 Kanto Branded Generics Landscape Analysis

    • 8.1 Kanto Branded Generics Landscape Analysis by Major Types

    • 8.2 Kanto Branded Generics Landscape Analysis by Major End-Users


    9 Chubu Branded Generics Landscape Analysis

    • 9.1 Chubu Branded Generics Landscape Analysis by Major Types

    • 9.2 Chubu Branded Generics Landscape Analysis by Major End-Users


    10 Kinki Branded Generics Landscape Analysis

    • 10.1 Kinki Branded Generics Landscape Analysis by Major Types

    • 10.2 Kinki Branded Generics Landscape Analysis by Major End-Users


    11 Chugoku Branded Generics Landscape Analysis

    • 11.1 Chugoku Branded Generics Landscape Analysis by Major Types

    • 11.2 Chugoku Branded Generics Landscape Analysis by Major End-Users


    12 Shikoku Branded Generics Landscape Analysis

    • 12.1 Shikoku Branded Generics Landscape Analysis by Major Types

    • 12.2 Shikoku Branded Generics Landscape Analysis by Major End-Users


    13 Kyushu Branded Generics Landscape Analysis

    • 13.1 Kyushu Branded Generics Landscape Analysis by Major Types

    • 13.2 Kyushu Branded Generics Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Aspen Pharmacare Holding

      • 14.1.1 Aspen Pharmacare Holding Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 Novartis AG

      • 14.2.1 Novartis AG Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Eva Pharmaceutical Industries

      • 14.3.1 Eva Pharmaceutical Industries Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 Sun Pharmaceutical Industries

      • 14.4.1 Sun Pharmaceutical Industries Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Mylan NV

      • 14.5.1 Mylan NV Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Pfizer

      • 14.6.1 Pfizer Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Valeant Pharmaceuticals International

      • 14.7.1 Valeant Pharmaceuticals International Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Abbott Laboratories

      • 14.8.1 Abbott Laboratories Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 84 Figures and 150 Tables)

     

    • Figure Japan Branded Generics Market Size and Growth Rate of Alkylating Agents from 2014 to 2026

    • Figure Japan Branded Generics Market Size and Growth Rate of Antimetabolites from 2014 to 2026

    • Figure Japan Branded Generics Market Size and Growth Rate of Hormones from 2014 to 2026

    • Figure Japan Branded Generics Market Size and Growth Rate of Anti-Hypertensive from 2014 to 2026

    • Figure Japan Branded Generics Market Size and Growth Rate of Lipid Lowering Drugs from 2014 to 2026

    • Figure Japan Branded Generics Market Size and Growth Rate of Anti-Depressants from 2014 to 2026

    • Figure Japan Branded Generics Market Size and Growth Rate of Anti-Psychotics from 2014 to 2026

    • Figure Japan Branded Generics Market Size and Growth Rate of Anti-Epileptics from 2014 to 2026

    • Figure Japan Branded Generics Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Branded Generics Market Size and Growth Rate of Oral from 2014 to 2026

    • Figure Japan Branded Generics Market Size and Growth Rate of Parenteral from 2014 to 2026

    • Figure Japan Branded Generics Market Size and Growth Rate of Topical from 2014 to 2026

    • Figure Japan Branded Generics Market Size and Growth Rate of Other from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Branded Generics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Branded Generics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Branded Generics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Branded Generics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Branded Generics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Branded Generics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Branded Generics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Branded Generics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Branded Generics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Branded Generics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Branded Generics by Different Types from 2014 to 2026

    • Table Consumption Share of Branded Generics by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Alkylating Agents

    • Figure Market Size and Growth Rate of Antimetabolites

    • Figure Market Size and Growth Rate of Hormones

    • Figure Market Size and Growth Rate of Anti-Hypertensive

    • Figure Market Size and Growth Rate of Lipid Lowering Drugs

    • Figure Market Size and Growth Rate of Anti-Depressants

    • Figure Market Size and Growth Rate of Anti-Psychotics

    • Figure Market Size and Growth Rate of Anti-Epileptics

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Branded Generics by Different End-Users from 2014 to 2026

    • Table Consumption Share of Branded Generics by Different End-Users from 2014 to 2026

    • Figure Japan Branded Generics Market Size and Growth Rate of Oral from 2014 to 2026

    • Figure Japan Branded Generics Market Size and Growth Rate of Parenteral from 2014 to 2026

    • Figure Japan Branded Generics Market Size and Growth Rate of Topical from 2014 to 2026

    • Figure Japan Branded Generics Market Size and Growth Rate of Other from 2014 to 2026

    • Table Japan Branded Generics Production by Regions

    • Table Japan Branded Generics Production Share by Regions

    • Figure Japan Branded Generics Production Share by Regions in 2014

    • Figure Japan Branded Generics Production Share by Regions in 2018

    • Figure Japan Branded Generics Production Share by Regions in 2026

    • Table Japan Branded Generics Consumption by Regions

    • Table Japan Branded Generics Consumption Share by Regions

    • Figure Japan Branded Generics Consumption Share by Regions in 2014

    • Figure Japan Branded Generics Consumption Share by Regions in 2018

    • Figure Japan Branded Generics Consumption Share by Regions in 2026

    • Table Hokkaido Branded Generics Consumption by Types from 2014 to 2026

    • Table Hokkaido Branded Generics Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Branded Generics Consumption Share by Types in 2014

    • Figure Hokkaido Branded Generics Consumption Share by Types in 2018

    • Figure Hokkaido Branded Generics Consumption Share by Types in 2026

    • Table Hokkaido Branded Generics Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Branded Generics Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Branded Generics Consumption Share by End-Users in 2014

    • Figure Hokkaido Branded Generics Consumption Share by End-Users in 2018

    • Figure Hokkaido Branded Generics Consumption Share by End-Users in 2026

    • Table Tohoku Branded Generics Consumption by Types from 2014 to 2026

    • Table Tohoku Branded Generics Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Branded Generics Consumption Share by Types in 2014

    • Figure Tohoku Branded Generics Consumption Share by Types in 2018

    • Figure Tohoku Branded Generics Consumption Share by Types in 2026

    • Table Tohoku Branded Generics Consumption by End-Users from 2014 to 2026

    • Table Tohoku Branded Generics Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Branded Generics Consumption Share by End-Users in 2014

    • Figure Tohoku Branded Generics Consumption Share by End-Users in 2018

    • Figure Tohoku Branded Generics Consumption Share by End-Users in 2026

    • Table Kanto Branded Generics Consumption by Types from 2014 to 2026

    • Table Kanto Branded Generics Consumption Share by Types from 2014 to 2026

    • Figure Kanto Branded Generics Consumption Share by Types in 2014

    • Figure Kanto Branded Generics Consumption Share by Types in 2018

    • Figure Kanto Branded Generics Consumption Share by Types in 2026

    • Table Kanto Branded Generics Consumption by End-Users from 2014 to 2026

    • Table Kanto Branded Generics Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Branded Generics Consumption Share by End-Users in 2014

    • Figure Kanto Branded Generics Consumption Share by End-Users in 2018

    • Figure Kanto Branded Generics Consumption Share by End-Users in 2026

    • Table Chubu Branded Generics Consumption by Types from 2014 to 2026

    • Table Chubu Branded Generics Consumption Share by Types from 2014 to 2026

    • Figure Chubu Branded Generics Consumption Share by Types in 2014

    • Figure Chubu Branded Generics Consumption Share by Types in 2018

    • Figure Chubu Branded Generics Consumption Share by Types in 2026

    • Table Chubu Branded Generics Consumption by End-Users from 2014 to 2026

    • Table Chubu Branded Generics Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Branded Generics Consumption Share by End-Users in 2014

    • Figure Chubu Branded Generics Consumption Share by End-Users in 2018

    • Figure Chubu Branded Generics Consumption Share by End-Users in 2026

    • Table Kinki Branded Generics Consumption by Types from 2014 to 2026

    • Table Kinki Branded Generics Consumption Share by Types from 2014 to 2026

    • Figure Kinki Branded Generics Consumption Share by Types in 2014

    • Figure Kinki Branded Generics Consumption Share by Types in 2018

    • Figure Kinki Branded Generics Consumption Share by Types in 2026

    • Table Kinki Branded Generics Consumption by End-Users from 2014 to 2026

    • Table Kinki Branded Generics Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Branded Generics Consumption Share by End-Users in 2014

    • Figure Kinki Branded Generics Consumption Share by End-Users in 2018

    • Figure Kinki Branded Generics Consumption Share by End-Users in 2026

    • Table Chugoku Branded Generics Consumption by Types from 2014 to 2026

    • Table Chugoku Branded Generics Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Branded Generics Consumption Share by Types in 2014

    • Figure Chugoku Branded Generics Consumption Share by Types in 2018

    • Figure Chugoku Branded Generics Consumption Share by Types in 2026

    • Table Chugoku Branded Generics Consumption by End-Users from 2014 to 2026

    • Table Chugoku Branded Generics Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Branded Generics Consumption Share by End-Users in 2014

    • Figure Chugoku Branded Generics Consumption Share by End-Users in 2018

    • Figure Chugoku Branded Generics Consumption Share by End-Users in 2026

    • Table Shikoku Branded Generics Consumption by Types from 2014 to 2026

    • Table Shikoku Branded Generics Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Branded Generics Consumption Share by Types in 2014

    • Figure Shikoku Branded Generics Consumption Share by Types in 2018

    • Figure Shikoku Branded Generics Consumption Share by Types in 2026

    • Table Shikoku Branded Generics Consumption by End-Users from 2014 to 2026

    • Table Shikoku Branded Generics Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Branded Generics Consumption Share by End-Users in 2014

    • Figure Shikoku Branded Generics Consumption Share by End-Users in 2018

    • Figure Shikoku Branded Generics Consumption Share by End-Users in 2026

    • Table Kyushu Branded Generics Consumption by Types from 2014 to 2026

    • Table Kyushu Branded Generics Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Branded Generics Consumption Share by Types in 2014

    • Figure Kyushu Branded Generics Consumption Share by Types in 2018

    • Figure Kyushu Branded Generics Consumption Share by Types in 2026

    • Table Kyushu Branded Generics Consumption by End-Users from 2014 to 2026

    • Table Kyushu Branded Generics Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Branded Generics Consumption Share by End-Users in 2014

    • Figure Kyushu Branded Generics Consumption Share by End-Users in 2018

    • Figure Kyushu Branded Generics Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Aspen Pharmacare Holding

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aspen Pharmacare Holding

    • Figure Sales and Growth Rate Analysis of Aspen Pharmacare Holding

    • Figure Revenue and Market Share Analysis of Aspen Pharmacare Holding

    • Table Product and Service Introduction of Aspen Pharmacare Holding

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

    • Table Company Profile and Development Status of Eva Pharmaceutical Industries

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eva Pharmaceutical Industries

    • Figure Sales and Growth Rate Analysis of Eva Pharmaceutical Industries

    • Figure Revenue and Market Share Analysis of Eva Pharmaceutical Industries

    • Table Product and Service Introduction of Eva Pharmaceutical Industries

    • Table Company Profile and Development Status of Sun Pharmaceutical Industries

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceutical Industries

    • Figure Sales and Growth Rate Analysis of Sun Pharmaceutical Industries

    • Figure Revenue and Market Share Analysis of Sun Pharmaceutical Industries

    • Table Product and Service Introduction of Sun Pharmaceutical Industries

    • Table Company Profile and Development Status of Mylan NV

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan NV

    • Figure Sales and Growth Rate Analysis of Mylan NV

    • Figure Revenue and Market Share Analysis of Mylan NV

    • Table Product and Service Introduction of Mylan NV

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Valeant Pharmaceuticals International

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharmaceuticals International

    • Figure Sales and Growth Rate Analysis of Valeant Pharmaceuticals International

    • Figure Revenue and Market Share Analysis of Valeant Pharmaceuticals International

    • Table Product and Service Introduction of Valeant Pharmaceuticals International

    • Table Company Profile and Development Status of Abbott Laboratories

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories

    • Figure Sales and Growth Rate Analysis of Abbott Laboratories

    • Figure Revenue and Market Share Analysis of Abbott Laboratories

    • Table Product and Service Introduction of Abbott Laboratories

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.